SHILPAMED.BO(SHILPAMED.BO)
SHILPAMED.BO
No analyst ratings available
No analyst price targets available for SHILPAMED.BO
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2027E | FY2028E | FY2029E | FY2030E | FY2031E |
|---|---|---|---|---|---|
| Revenue Avg | $17.50B | $20.78B | $22.81B | $26.91B | $31.69B |
| Low | $17.20B | $19.54B | $21.90B | $25.83B | $30.42B |
| High | $17.81B | $22.01B | $23.73B | $27.99B | $32.97B |
| EBITDA Avg | $3.65B | $4.33B | $4.75B | $5.61B | $6.60B |
| Low | $3.58B | $4.07B | $4.56B | $5.38B | $6.34B |
| High | $3.71B | $4.59B | $4.94B | $5.83B | $6.87B |
| EBIT Avg | $2.17B | $2.58B | $2.83B | $3.34B | $3.94B |
| Low | $2.14B | $2.43B | $2.72B | $3.21B | $3.78B |
| High | $2.21B | $2.73B | $2.95B | $3.48B | $4.10B |
| Net Income Avg | $2.40B | $3.23B | $3.48B | $4.46B | $5.65B |
| Low | $2.30B | $3.10B | $3.30B | $4.23B | $5.36B |
| High | $2.49B | $3.36B | $3.66B | $4.69B | $5.95B |
| EPS Avg | $12.25 | $16.50 | $17.80 | $22.80 | $28.90 |
| Low | $11.76 | $15.83 | $16.87 | $21.61 | $27.39 |
| High | $12.74 | $17.17 | $18.73 | $23.99 | $30.41 |
| Analysts (Rev / EPS) | 2 / 2 | 2 / 2 | 1 / 1 | 1 / 1 | 1 / 1 |